A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Entegris Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 21,686 shares of ENTG stock, worth $2.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,686
Previous 6,068 257.38%
Holding current value
$2.22 Million
Previous $822,000 196.84%
% of portfolio
0.01%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$98.09 - $146.48 $1.53 Million - $2.29 Million
15,618 Added 257.38%
21,686 $2.44 Million
Q2 2024

Jul 26, 2024

BUY
$122.2 - $140.62 $28,717 - $33,045
235 Added 4.03%
6,068 $822,000
Q1 2024

Apr 24, 2024

SELL
$109.04 - $145.37 $176,753 - $235,644
-1,621 Reduced 21.75%
5,833 $820,000
Q4 2023

Feb 09, 2024

BUY
$85.71 - $121.6 $685 - $972
8 Added 0.11%
7,454 $893,000
Q3 2023

Oct 24, 2023

SELL
$88.82 - $112.45 $31,708 - $40,144
-357 Reduced 4.58%
7,446 $699,000
Q2 2023

Jul 13, 2023

SELL
$69.37 - $113.76 $5,549 - $9,100
-80 Reduced 1.01%
7,803 $865,000
Q1 2023

May 11, 2023

BUY
$64.13 - $87.93 $2,949 - $4,044
46 Added 0.59%
7,883 $646,000
Q4 2022

Feb 08, 2023

BUY
$62.71 - $90.32 $491,458 - $707,837
7,837 New
7,837 $514,000
Q2 2022

Jul 13, 2022

SELL
$92.0 - $125.13 $263,672 - $358,622
-2,866 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$109.73 - $140.83 $133,102 - $170,826
1,213 Added 73.38%
2,866 $376,000
Q4 2021

Feb 03, 2022

SELL
$120.15 - $154.75 $9,251 - $11,915
-77 Reduced 4.45%
1,653 $229,000
Q3 2021

Nov 02, 2021

SELL
$111.63 - $134.83 $11,944 - $14,426
-107 Reduced 5.82%
1,730 $217,000
Q2 2021

Aug 10, 2021

BUY
$101.61 - $123.26 $186,657 - $226,428
1,837 New
1,837 $225,000

Others Institutions Holding ENTG

About ENTEGRIS INC


  • Ticker ENTG
  • Exchange NASDAQ
  • Sector Technology
  • Industry Semiconductor Equipment & Materials
  • Shares Outstandng 148,964,000
  • Market Cap $15.2B
  • Description
  • Entegris, Inc. develops, manufactures, and supplies microcontamination control products, specialty chemicals, and advanced materials handling solutions in North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. It operates in three segments: Specialty Chemicals and Engineered Materials (SCEM); Microcontamination Control (MC...
More about ENTG
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.